Please assess the completion status of the following clinical trial:

Trial Title: BIOTRONIK Conduction System Pacing with the Solia Lead

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patient is a candidate for implantation of a BIOTRONIK pacemaker system, per standard guidelines. Single chamber, dual chamber, and CRT-P systems are allowed.~* Patient has an implant planned to utilize left bundle branch area pacing within 30 days of consent~* Patient is able to understand the nature of the study and provide written informed consent~* Patient is available for follow-up visits on a regular basis for the expected duration of follow-up~* Patient accepts Home Monitoring® concept~* Patient age is greater than or equal to 18 years at time of consent~Exclusion Criteria:~* Patient meets a standard contraindication for pacemaker system implant~* Patient is currently implanted with a pacemaker or ICD device~* Patient has had a previous unsuccessful attempt to place a lead in the LBB area~* Patient has planned cardiac surgical procedures or interventional measures within 3 months after implant~* Patient is expected to receive a heart transplant within 12 months~* Patient life expectancy less than 12 months~* Patient has the presence of another life-threatening, underlying illness separate from their cardiac disorder~* Patient reports pregnancy at the time of enrollment~* Patient is enrolled in any other investigational cardiac clinical study during the course of the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Solia S LBB lead (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).